Abstract 327: The impact of PIK3CA/PTEN/AKT1 genes in advanced NSCLC patients with acquired EGFR-TKI resistance and clinical response to EGFR-TKI plus everolimus combination therapy

Mapping Intimacies ◽

10.1158/1538-7445.am2019-327 ◽

2019 ◽

Author(s):

Wenfeng Fang ◽

Yihua Huang ◽

Jiadi Gan ◽

Yunpeng Yang ◽

Yifen Wu ◽

...

Keyword(s):

Combination Therapy ◽

Clinical Response ◽

Advanced Nsclc ◽

Tki Resistance ◽

Nsclc Patients ◽

Download Full-text

Abstract 327: The impact of PIK3CA/PTEN/AKT1 genes in advanced NSCLC patients with acquired EGFR-TKI resistance and clinical response to EGFR-TKI plus everolimus combination therapy

10.1158/1538-7445.sabcs18-327 ◽

2019 ◽

Author(s):

Wenfeng Fang ◽

Yihua Huang ◽

Jiadi Gan ◽

Yunpeng Yang ◽

Yifen Wu ◽

...

Keyword(s):

Combination Therapy ◽

Clinical Response ◽

Advanced Nsclc ◽

Tki Resistance ◽

Nsclc Patients ◽

Download Full-text

PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy

Translational Lung Cancer Research ◽

10.21037/tlcr-20-141 ◽

2020 ◽

Vol 9 (4) ◽

pp. 1258-1267

Author(s):

Wenfeng Fang ◽

Yihua Huang ◽

Weiguang Gu ◽

Jiadi Gan ◽

Wenjing Wang ◽

...

Keyword(s):

Combination Therapy ◽

Clinical Response ◽

Advanced Nsclc ◽

Mtor Pathway ◽

Nsclc Patients ◽

Download Full-text

HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy

OncoTargets and Therapy ◽

10.2147/ott.s335217 ◽

2021 ◽

Vol Volume 14 ◽

pp. 5297-5307

Author(s):

Jiadi Gan ◽

Yihua Huang ◽

Jun Liao ◽

Lanlan Pang ◽

Wenfeng Fang

Keyword(s):

Combination Therapy ◽

Clinical Response ◽

Advanced Nsclc ◽

Her2 Amplification ◽

Nsclc Patients ◽

Download Full-text

Association of plasma EGFR T790M ctDNA status with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.8080 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 8080-8080

Author(s):

Di Zheng ◽

Xin Ye ◽

Meizhuo Zhang ◽

Yun Sun ◽

Jiying Wang ◽

...

Keyword(s):

Clinical Outcome ◽

Advanced Nsclc ◽

Tki Resistance ◽

Nsclc Patients ◽

Egfr Tki ◽

Download Full-text

A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance

Cancer Medicine ◽

10.1002/cam4.978 ◽

2016 ◽

Vol 6 (1) ◽

pp. 154-162 ◽

Author(s):

Wenxian Wang ◽

Zhengbo Song ◽

Yiping Zhang

Keyword(s):

Advanced Nsclc ◽

Tki Resistance ◽

Nsclc Patients ◽

Egfr Tki ◽

Download Full-text

JCES01.09 A Comparison of ddPCR and ARMS for Detecting EGFR T790M Status from Advanced NSCLC Patients with Acquired EGFR-TKI Resistance

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.211 ◽

2017 ◽

Vol 12 (1) ◽

pp. S233

Author(s):

Wenxian Wang ◽

Zhengbo Song ◽

Yiping Zhang ◽

Ying Jin

Keyword(s):

Advanced Nsclc ◽

Tki Resistance ◽

Nsclc Patients ◽

Egfr Tki ◽

Download Full-text

Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance

Scientific Reports ◽

10.1038/srep20913 ◽

2016 ◽

Vol 6 (1) ◽

Author(s):

D. Zheng ◽

X. Ye ◽

M. Z. Zhang ◽

Y. Sun ◽

J. Y. Wang ◽

...

Keyword(s):

Clinical Outcome ◽

Advanced Nsclc ◽

Tki Resistance ◽

Nsclc Patients ◽

Egfr Tki ◽

Download Full-text

P3.02b-040 A Comparison of ddPCR and ARMS for Detecting EGFR T790M Status from Advanced NSCLC Patients with Acquired EGFR-TKI Resistance

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.1707 ◽

2017 ◽

Vol 12 (1) ◽

pp. S1211

Author(s):

Wenxian Wang ◽

Zhengbo Song ◽

Yiping Zhang ◽

Ying Jin

Keyword(s):

Advanced Nsclc ◽

Tki Resistance ◽

Nsclc Patients ◽

Egfr Tki ◽

Download Full-text

Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI

Case Medical Research ◽

10.31525/ct1-nct04007835 ◽

2019 ◽

Author(s):

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Advanced Nsclc ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Nsclc Patients ◽

Download Full-text

P19.01 Local Ablative Radiotherapy on Oligo-Progression while Continued on EGFR-TKI in Advanced NSCLC Patients: A Longer Cohort

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.562 ◽

2021 ◽

Vol 16 (3) ◽

pp. S355

Author(s):

F.S.T. Mok ◽

M. Tong ◽

H. Loong ◽

T. Mok

Keyword(s):

Advanced Nsclc ◽

Nsclc Patients ◽

Download Full-text